Xenon lighting for neurosurgery

NICO Corporation, a company based in Indianapolis, Indiana, is releasing its new Myriad Novus resection tool. The FDA cleared product combines xenon illumination with NICO’s proven Myriad neural tissue removal technology.

Xenon lights reproduce the visible spectrum of daylight much better than most other bulbs – although LED contenders are now available – and so are often the optimal choice when working in a confined environment and where precision is key.

Microscope, surgical loupe or exoscope

The Myriad Novus is intended to help with intracerebral hemorrhage clot evacuation and subcortical tumor resection, whether using a microscope, surgical loupe, or an exoscope. The company claims that it provides, “for the first time ever, automated and intraoperative tissue harvesting for post-procedural analysis in the modern molecular era.”

The technology gives surgeons one solution for intracerebral hemorrhage clot evacuation and subcortical tumor resection whether using a microscope, surgical loupes or an exoscope. Its capabilities include illumination offering enhanced visualization with the surgeon’s preferred optical platform, improved in-situ tissue identification, non-ablative and non-thermal resection, automated tissue harvesting with the ability to annotate by intratumoral location, and biological preservation of harvested tissue for post-procedural analysis.

More versatility for surgeons

“The Novus represents the next generation of NICO’s flagship product – the Myriad,” said Jim Pearson, President and CEO of NICO Corporation. “We are excited to give surgeons more versatility across minimally invasive port access, endoscopic, and skull base surgical approaches while still addressing their needs surrounding procedural efficiencies and convenience.”

18.11.2019